Status:
COMPLETED
Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.
Lead Sponsor:
Biodel
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
40-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the effects of insulin VIAject with Regular Human Insulin and Insulin Lispro on measures of mealtime blood vessel stress and blood flow.
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus according to the ADA criteria
- HbA1c between 6.5 % and 9.9 %
- Treatment with sulfonylurea and/or metformin in a stable dosage within the last 3 months
- Age between 40 and 75 years
- BMI \< 40
Exclusion
- Type 1 diabetes mellitus
- Pre-treatment with insulin within the last 6 months prior to screening
- Pre-treatment with PPARy-agonists or glucosidase inhibitors within the last 4 weeks prior to screening
- Untreated hypertension stage II-III according to WHO criteria
- Planned or anticipated change in antidiabetic and/or concomitant medication during study participation
- Total cholesterol \> 300 mg/dl (anamnestically)
- Major micro- or macrovascular complications as judged by the investigator
- Tobacco use within the last 6 months prior to screening
- Drugs with major impact on endothelial function like nitrates etc.
- History of drug or alcohol abuse which in the opinion of the investigator will impair subject safety or protocol compliance
- History of hypersensitivity to the study drugs or to drugs with similar chemical structures
- History of severe or multiple allergies
- Treatment with any other investigational drug within 3 months prior to screening
- Progressive fatal disease
- History of significant cardiovascular, respiratory, gastrointestinal, hepatic (ALAT and/or ASAT \> 3 times the normal reference range), renal (creatinine \> 1.1 mg/dL in women and \> 1.5 mg/dL in men), neurological, psychiatric and/or haematological disease as judged by the investigator
- Pregnancy or breast feeding
- Sexually active women of childbearing potential not consistently and correctly practicing birth control by implants, injectables, oral contraceptives, hormonal intrauterine devices (IUDs), sexual abstinence or vasectomised partner
- Lack of compliance or other similar reason that at the discretion of the investigator precludes satisfactory participation in the study
- Hypopotassemia (K\<3.5 mmol /l)
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00849576
Start Date
April 1 2008
End Date
August 1 2008
Last Update
August 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IKFE
Parcusstrasse 8, Mainz, Germany, 55116